Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2024-02-14

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.0bn reported value +13.2% vs Q3 2023
55positions
63.4%in top 10
4 new 21 added 27 reduced 10 sold out vs Q3 2023

Options: 0 call positions (— notional), 2 put positions ($118.5m notional) – listed below, not included above.

Holdings, Q4 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NATERA INC COM NTRA NTRA 2,251,588 $141.0m13.83% 13.83% ReducedShares held: Q1 2023 2.8m, Q2 2023 2.4m, Q3 2023 2.5m, Q4 2023 2.3m -241.0k -241,048 -9.7%
2 GSK PLC SPONSORED ADR GSK GSK 2,972,954 $110.2m10.80% 10.80% ReducedShares held: Q1 2023 3.7m, Q2 2023 2.9m, Q3 2023 3.3m, Q4 2023 3.0m -286.4k -286,388 -8.8%
3 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 3,383,244 $73.1m7.17% 7.17% AddedShares held: Q1 2023 2.2m, Q2 2023 2.2m, Q3 2023 2.6m, Q4 2023 3.4m +787.0k +786,999 30.3%
4 INSPIRE MED SYS INC COM INSP INSP 351,116 $71.4m7.00% 7.00% AddedShares held: Q1 2023 0, Q2 2023 82.4k, Q3 2023 193.0k, Q4 2023 351.1k +158.1k +158,098 81.9%
5 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 6,154,354 $64.3m6.30% 6.30% ReducedShares held: Q1 2023 6.2m, Q2 2023 7.7m, Q3 2023 7.0m, Q4 2023 6.2m -797.7k -797,731 -11.5%
6 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 246,234 $54.1m5.31% 5.31% ReducedShares held: Q1 2023 222.1k, Q2 2023 260.4k, Q3 2023 267.9k, Q4 2023 246.2k -21.7k -21,669 -8.1%
7 BIO-TECHNE CORP COM TECH TECH 465,307 $35.9m3.52% 3.52% AddedShares held: Q1 2023 188.7k, Q2 2023 342.6k, Q3 2023 385.9k, Q4 2023 465.3k +79.4k +79,418 20.6%
8 HEALTHEQUITY INC COM HQY HQY 494,919 $32.8m3.22% 3.22% AddedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 338.5k, Q4 2023 494.9k +156.4k +156,403 46.2%
9 ARGENX SE SPONSORED ADR ARGX ARGX 85,832 $32.7m3.20% 3.20% AddedShares held: Q1 2023 3.8k, Q2 2023 4.2k, Q3 2023 4.6k, Q4 2023 85.8k +81.3k +81,267 1780.2%
10 HCA HEALTHCARE INC COM HCA HCA 114,805 $31.1m3.05% 3.05% AddedShares held: Q1 2023 27.9k, Q2 2023 80.7k, Q3 2023 110.1k, Q4 2023 114.8k +4.7k +4,732 4.3%
11 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 754,107 $29.9m2.93% 2.93% AddedShares held: Q1 2023 689.7k, Q2 2023 785.7k, Q3 2023 588.1k, Q4 2023 754.1k +166.0k +165,964 28.2%
12 VERA THERAPEUTICS INC CL A VERA VERA 1,914,830 $29.5m2.89% 2.89% AddedShares held: Q1 2023 1.8m, Q2 2023 1.7m, Q3 2023 1.5m, Q4 2023 1.9m +436.3k +436,341 29.5%
13 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 7,231,126 $22.6m2.22% 2.22% AddedShares held: Q1 2023 9.1m, Q2 2023 7.3m, Q3 2023 7.1m, Q4 2023 7.2m +85.0k +85,038 1.2%
14 IMMUNOGEN INC COM IMGN IMGN 748,950 $22.2m2.18% 2.18% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 749.0k
15 REVVITY INC COM RVTY RVTY 183,059 $20.0m1.96% 1.96% AddedShares held: Q1 2023 12.3k, Q2 2023 21.3k, Q3 2023 32.7k, Q4 2023 183.1k +150.4k +150,361 459.9%
16 IONIS PHARMACEUTICALS INC COM IONS IONS 324,654 $16.4m1.61% 1.61% AddedShares held: Q1 2023 303.4k, Q2 2023 241.6k, Q3 2023 252.4k, Q4 2023 324.7k +72.2k +72,208 28.6%
17 VAXCYTE INC COM PCVX PCVX 233,839 $14.7m1.44% 1.44% AddedShares held: Q1 2023 299.1k, Q2 2023 195.7k, Q3 2023 190.4k, Q4 2023 233.8k +43.4k +43,409 22.8%
18 SHOCKWAVE MED INC COM SWAV SWAV 75,822 $14.4m1.42% 1.42% ReducedShares held: Q1 2023 47.6k, Q2 2023 20.1k, Q3 2023 84.5k, Q4 2023 75.8k -8.6k -8,640 -10.2%
19 TENET HEALTHCARE CORP COM NEW THC THC 187,265 $14.2m1.39% 1.39% NewShares held: Q1 2023 141.9k, Q2 2023 0, Q3 2023 0, Q4 2023 187.3k
20 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 538,074 $12.3m1.21% 1.21% AddedShares held: Q1 2023 0, Q2 2023 114.7k, Q3 2023 286.7k, Q4 2023 538.1k +251.3k +251,326 87.7%
21 ILLUMINA INC COM ILMN ILMN 86,614 $12.1m1.18% 1.18% ReducedShares held: Q1 2023 170.5k, Q2 2023 124.1k, Q3 2023 166.8k, Q4 2023 86.6k -80.2k -80,168 -48.1%
22 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 255,988 $10.7m1.05% 1.05% AddedShares held: Q1 2023 245.3k, Q2 2023 250.3k, Q3 2023 255.3k, Q4 2023 256.0k +665 +665 0.3%
23 KRYSTAL BIOTECH INC COM KRYS KRYS 80,798 $10.0m0.98% 0.98% ReducedShares held: Q1 2023 0, Q2 2023 106.5k, Q3 2023 108.8k, Q4 2023 80.8k -28.0k -27,973 -25.7%
24 ZIMVIE INC COM ZIMV ZIMV 546,444 $9.7m0.95% 0.95% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 546.4k
25 DANAHER CORPORATION COM DHR DHR 41,041 $9.5m0.93% 0.93% ReducedShares held: Q1 2023 148.7k, Q2 2023 103.3k, Q3 2023 103.8k, Q4 2023 41.0k -62.7k -62,743 -60.5%
26 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 1,529,047 $9.2m0.90% 0.90% ReducedShares held: Q1 2023 4.5m, Q2 2023 2.4m, Q3 2023 2.5m, Q4 2023 1.5m -950.1k -950,056 -38.3%
27 WATERS CORP COM WAT WAT 27,719 $9.1m0.89% 0.89% AddedShares held: Q1 2023 0, Q2 2023 10.9k, Q3 2023 23.1k, Q4 2023 27.7k +4.6k +4,595 19.9%
28 LIQUIDIA CORPORATION COM NEW LQDA LQDA 688,926 $8.3m0.81% 0.81% ReducedShares held: Q1 2023 724.4k, Q2 2023 925.4k, Q3 2023 1.4m, Q4 2023 688.9k -706.5k -706,528 -50.6%
29 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 1,695,021 $7.3m0.72% 0.72% AddedShares held: Q1 2023 1.9m, Q2 2023 1.7m, Q3 2023 1.7m, Q4 2023 1.7m +13.9k +13,872 0.8%
30 CENTENE CORP DEL COM CNC CNC 97,198 $7.2m0.71% 0.71% ReducedShares held: Q1 2023 288.4k, Q2 2023 152.7k, Q3 2023 190.6k, Q4 2023 97.2k -93.4k -93,409 -49.0%
31 ELEVANCE HEALTH INC COM ELV ELV 15,094 $7.1m0.70% 0.70% ReducedShares held: Q1 2023 0, Q2 2023 2.3k, Q3 2023 21.7k, Q4 2023 15.1k -6.6k -6,600 -30.4%
32 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 3,780,714 $6.7m0.66% 0.66% AddedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 1.7m, Q4 2023 3.8m +2.1m +2,074,940 121.6%
33 GOSSAMER BIO INC COM GOSS GOSS 6,432,715 $5.9m0.58% 0.58% AddedShares held: Q1 2023 1.4m, Q2 2023 749.7k, Q3 2023 4.4m, Q4 2023 6.4m +2.0m +2,004,858 45.3%
34 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 6,095,505 $5.3m0.52% 0.52% ReducedShares held: Q1 2023 0, Q2 2023 10.5m, Q3 2023 8.4m, Q4 2023 6.1m -2.3m -2,336,370 -27.7%
35 AGILENT TECHNOLOGIES INC COM A A 37,854 $5.3m0.52% 0.52% ReducedShares held: Q1 2023 13.1k, Q2 2023 28.5k, Q3 2023 41.8k, Q4 2023 37.9k -4.0k -3,971 -9.5%
36 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 1,139,111 $4.9m0.48% 0.48% ReducedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 1.5m, Q4 2023 1.1m -314.3k -314,267 -21.6%
37 IMMUNOVANT INC COM IMVT IMVT 113,793 $4.8m0.47% 0.47% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 113.8k
38 SUTRO BIOPHARMA INC COM COM 1,056,461 $4.5m0.44% 0.44% AddedShares held: Q1 2023 0, Q2 2023 747.9k, Q3 2023 769.6k, Q4 2023 1.1m +286.8k +286,823 37.3%
39 ICON PLC SHS ICLR ICLR 15,417 $4.4m0.43% 0.43% ReducedShares held: Q1 2023 76.8k, Q2 2023 71.7k, Q3 2023 21.0k, Q4 2023 15.4k -5.6k -5,581 -26.6%
40 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 374,404 $4.2m0.41% 0.41% ReducedShares held: Q1 2023 45.9k, Q2 2023 692.4k, Q3 2023 660.6k, Q4 2023 374.4k -286.2k -286,214 -43.3%
41 MERUS N V COM MRUS MRUS 115,726 $3.2m0.31% 0.31% ReducedShares held: Q1 2023 129.1k, Q2 2023 131.2k, Q3 2023 134.0k, Q4 2023 115.7k -18.3k -18,284 -13.6%
42 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 137,343 $3.0m0.29% 0.29% ReducedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 443.3k, Q4 2023 137.3k -305.9k -305,927 -69.0%
43 AVANTOR INC COM AVTR AVTR 125,964 $2.9m0.28% 0.28% AddedShares held: Q1 2023 717.6k, Q2 2023 0, Q3 2023 84.5k, Q4 2023 126.0k +41.5k +41,469 49.1%
44 BIOHAVEN LTD COM BHVN BHVN 66,898 $2.9m0.28% 0.28% ReducedShares held: Q1 2023 185.6k, Q2 2023 131.1k, Q3 2023 131.1k, Q4 2023 66.9k -64.2k -64,205 -49.0%
45 IQVIA HLDGS INC COM IQV IQV 12,263 $2.8m0.28% 0.28% ReducedShares held: Q1 2023 14.4k, Q2 2023 18.7k, Q3 2023 23.0k, Q4 2023 12.3k -10.8k -10,778 -46.8%
46 SERES THERAPEUTICS INC COM COM 1,753,538 $2.5m0.24% 0.24% ReducedShares held: Q1 2023 2.5m, Q2 2023 3.1m, Q3 2023 2.4m, Q4 2023 1.8m -599.0k -599,018 -25.5%
47 MOLINA HEALTHCARE INC COM MOH MOH 6,117 $2.2m0.22% 0.22% ReducedShares held: Q1 2023 0, Q2 2023 21.3k, Q3 2023 12.2k, Q4 2023 6.1k -6.1k -6,117 -50.0%
48 INFLARX NV COM IFRX IFRX 1,305,140 $2.1m0.21% 0.21% ReducedShares held: Q1 2023 0, Q2 2023 1.9m, Q3 2023 1.7m, Q4 2023 1.3m -432.4k -432,404 -24.9%
49 CUREVAC N V COM CVAC CVAC 496,912 $2.1m0.21% 0.21% ReducedShares held: Q1 2023 0, Q2 2023 357.3k, Q3 2023 516.8k, Q4 2023 496.9k -19.9k -19,882 -3.9%
50 REPLIGEN CORP COM RGEN RGEN 9,984 $1.8m0.18% 0.18% ReducedShares held: Q1 2023 5.7k, Q2 2023 66.1k, Q3 2023 16.2k, Q4 2023 10.0k -6.2k -6,169 -38.2%
51 XOMA ROYALTY CORPORATION COM NEW XOMA XOMA 93,727 $1.7m0.17% 0.17% AddedShares held: Q1 2023 90.0k, Q2 2023 90.0k, Q3 2023 90.0k, Q4 2023 93.7k +3.8k +3,777 4.2%
52 AEROVATE THERAPEUTICS INC COM COM 50,242 $1.1m0.11% 0.11% UnchangedShares held: Q1 2023 50.2k, Q2 2023 50.2k, Q3 2023 50.2k, Q4 2023 50.2k
53 AFFIMED N V COM COM 1,676,684 $1.0m0.10% 0.10% UnchangedShares held: Q1 2023 1.9m, Q2 2023 1.7m, Q3 2023 1.7m, Q4 2023 1.7m
54 HUMANA INC COM HUM HUM 1,914 $876.2k0.09% 0.09% ReducedShares held: Q1 2023 22.8k, Q2 2023 11.9k, Q3 2023 18.1k, Q4 2023 1.9k -16.2k -16,207 -89.4%
55 AC IMMUNE SA SHS ACIU ACIU 124,589 $622.9k0.06% 0.06% UnchangedShares held: Q1 2023 124.6k, Q2 2023 124.6k, Q3 2023 124.6k, Q4 2023 124.6k

Sold out since Q3 2023

SecurityTickerShares held beforeValue then
HORIZON THERAPEUTICS PUB L HZNP HZNP 205,815 $23.8m205.8k shares
AMNEAL PHARMACEUTICALS INC AMRX AMRX 2,644,988 $11.2m2.6m shares
APELLIS PHARMACEUTICALS INC APLS APLS 122,643 $4.7m122.6k shares
MARAVAI LIFESCIENCES HLDGS I MRVI MRVI 452,323 $4.5m452.3k shares
PENNANT GROUP INC PNTG PNTG 365,899 $4.1m365.9k shares
INSULET CORP PODD PODD 21,299 $3.4m21.3k shares
MEDPACE HLDGS INC MEDP MEDP 8,823 $2.1m8.8k shares
SPDR SER TR XBI XBI 20,000 $1.5m20.0k shares
BLACK DIAMOND THERAPEUTICS I BDTX BDTX 337,131 $967.6k337.1k shares
AADI BIOSCIENCE INC WHWK WHWK 101,918 $493.3k101.9k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 150,000 $61.4m150.0k shares Reduced
SPDR S&P 500 ETF TR SPY · Put SPYPut 120,000 $57.0m120.0k shares Reduced

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17